Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Vitamin D3 is one of the few natural compounds that has, via its metabolite 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and the transcription factor vitamin D receptor (VDR), a direct effect on gene regulation. For efficiently applying the therapeutic and disease-preventing potential of 1,25(OH)2D3 and its synthetic analogs, the key steps in vitamin D signaling need to be understood. These are the different types of molecular interactions with the VDR, such as (i) the complex formation of VDR with genomic DNA, (ii) the interaction of VDR with its partner transcription factors, (iii) the binding of 1,25(OH)2D3 or its synthetic analogs within the ligand-binding pocket of the VDR, and (iv) the resulting conformational change on the surface of the VDR leading to a change of the protein-protein interaction profile of the receptor with other proteins. This review will present the latest genome-wide insight into vitamin D signaling, and will discuss its therapeutic implications.
School of Medicine, Institute of Biomedicine, University of Eastern Finland, POB 1627, FI-70211 Kuopio, Finland.
Carsten
C
Carlberg
Ferdinand
F
Molnár
D000818:Animals; D055106:Genome-Wide Association Study / Q000639:trends; D006801:Humans; D011485:Protein Binding / Q000502:physiology; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D018167:Receptors, Calcitriol / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*
D018167:Receptors, Calcitriol
VDR partner proteins; analogues de la vitamine D; chromatin immunoprecipitation; crystal structure; immunoprécipitation de chromatine; protéines partenaires du VDR; signalisation de la vitamine D in vivo; structure cristalline; vitamin D; vitamin D analogs; vitamin D signaling in vivo; vitamine D